Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder where early diagnosis serves as the only viable window for effective intervention. While Structural MRI (sMRI) is a primary clinical tool for this purpose, manual diagnosis is heavily constrained by clinician expertise and the difficulty of visually quantifying subtle, diffuse anatomical changes. Deep learning has emerged as a ...
BackgroundAging causes declines in cognitive and motor functions, often manifested in altered gait. Dual-task gait is a sensitive marker for early functional changes. This study investigated whether neural network (NN) models can differentiate gait patterns across age groups under dual-task conditions, and which joint features contribute most to age classification.MethodsThirty-six healthy were re...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by multifactorial pathology, including amyloid-β (Aβ) aggregation, ...
BackgroundTelomere dysfunction contributes to cellular aging and genome instability, but telomere-associated transcription in Alzheimer's disease (AD)...
BACKGROUND: Predicting cognitive decline as a continuum, from healthy age-related decline to mild cognitive impairment and dementia, enables more prec...
TAR DNA-binding protein 43 (TDP-43) inclusions are often associated with hyperphosphorylated tau, thus neurofibrillary tangles as the hallmark of Alzh...
BACKGROUND: Neuroimaging with [18F]FDG PET can support the diagnosis of Dementia with Lewy Bodies (DLB), but it remains unclear how genetic factors in...
BACKGROUND: Lewy body diseases (LBD) collectively share α-synuclein Lewy pathology, yet present wide clinical heterogeneity, with overlapping motor an...
Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by widespread dysregulation of gene expression and regulatory pathways....
Positron Emission Tomography (PET) is an important molecular imaging tool widely used in medicine. Traditional PET systems rely on complete detector r...
PURPOSE: QQ, a recently proposed oxygen extraction fraction (OEF) mapping technique combining quantitative susceptibility mapping (QSM) and quantitati...
BACKGROUND: Best practices in diagnosing autism spectrum disorder require an expert diagnostician to integrate multiple sources of information, includ...
BACKGROUND: Thirty-day unplanned readmission following coronary artery bypass grafting (CABG) affects 10%-20% of patients and is a key quality indicat...
Alzheimer's disease is a complex neurodegenerative disorder and the leading cause of dementia worldwide. Learning-based techniques applied to magnetic...
Brain aging, the strongest risk factor for Alzheimer's disease (AD), varies across cortical regions. Global brain age (GBA), an imaging-derived measur...
PURPOSE: Large artery stenosis (LAS) can drive cognitive impairment and neurodegeneration even without overt infarction, yet scalable biomarkers for c...
Artificial intelligence (AI) has achieved remarkable success in the diagnosis of Alzheimer's disease (AD) in the literature, where many of the models ...
BACKGROUND: Telemedicine is conventionally modeled as a dyadic clinician-patient encounter, yet a third party-caregiver, community health worker, nurs...
Alzheimer's disease (AD) classification from structural magnetic resonance imaging (MRI) remains challenging, particularly when distinguishing mild co...
Deep mutational scanning (DMS) has proven effective for mapping protein-protein interactions (PPIs), but it cannot provide complete coverage of the mu...